WHO cautions lifting of coronavirus lockdowns must be steady Kumar Jeetendra | April 21, 2020 Lockdown measures have demonstrated compelling, and individuals must be prepared for another method for living to permit society to work while the coronavirus is being held under tight restraints, said Takeshi Kasai, WHO Regional Director The World Health Organization cautioned on Tuesday that any lifting of lockdowns to contain the spread of the novel coronavirus …
Pfizer, BioNTech’s coronavirus immunizations get FDA’s ‘most optimized plan of attack’ status Kumar Jeetendra | July 13, 2020 The candidates, both BNT162b1 and BNT162b2, would be the most complex of at least four vaccines getting analyzed by most firms in ongoing trials in the United States and Germany. Pfizer’s shares were up roughly 2% and U.S.-listed stocks of BioNTech were up roughly 6 percent before the bell. Earlier this month, the firms said …
Phase 2 preliminary discovers Chinese COVID-19 antibody is sheltered, incites insusceptible reaction: Lancet study Kumar Jeetendra | July 21, 2020 A phase II clinical trial of a COVID-19 vaccine candidate, conducted in China, has found it is safe and causes an immune reaction, a study published in The Lancet says. Researchers, for example those from the Center for Disease Control and Prevention, said the trial sought to assess the safety and immunogenicity of this vaccine …
